Short-course radiation to ease symptoms from head and neck cancer
Part of Cancer clinical trials.
This Phase 2 trial tests a specific, shorter type of focused radiation to help relieve symptoms from head and neck squamous cell carcinoma. It compares two radiation timing/planning approaches to see which better improves comfort and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and can sign informed consent
- Your cancer is squamous cell carcinoma found in the head and neck area
- Your care team says your cancer is not treatable with a cure (palliative treatment only)
- You can safely receive radiation therapy (no major reasons you can’t have it)
- You are not pregnant or breastfeeding
- You can complete recent exams, scans, and symptom/pain questionnaires before treatment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation for people with intermediate-risk head and neck cancer after surgery. It aims to reduce side effects while keeping treatment effective.
This trial tests whether giving a slightly different schedule of radiation (more frequent, smaller doses) can improve treatment for people with large head and neck cancers. It is for patients who are getting radiation as their main treatment, sometimes with chemotherapy as well.
This Phase 2 trial tests whether planning radiation based on an imaging scan (F-MISO PET) can better target oxygen-poor (low-oxygen) tumor areas in head and neck cancer. It may help make radiation more precise while still using standard curative treatment.
This trial looks at whether giving less (de-escalated) radiation after surgery is as effective and safer for people with locally advanced head and neck squamous cell carcinoma who had a strong response to treatment before surgery. If you had no remaining cancer or only very small amounts of cancer left in the surgical specimen, this approach may help reduce side effects while keeping control of the disease.
This trial tests whether combining radiation therapy with immunotherapy works better than immunotherapy alone for advanced head and neck cancer that hasn't been treated before. The goal is to help your body's immune system fight the cancer more effectively.
This Phase 2 study tests whether giving low-dose radiation before surgery—along with chemotherapy and an immunotherapy drug—can work better and be safe for treating locally advanced head and neck squamous cell cancer. It may help shrink tumors before surgery and reduce the chance of the cancer coming back.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.